AUTHOR=Wen Shirui , Huang Kailing , Zhu Haoyue , Li Peihong , Zhou Luo , Feng Li 

TITLE=Case Report: Anti-NF186+ CIDP After Receiving the Inactivated Vaccine for Coronavirus Disease (COVID-19)

JOURNAL=Frontiers in Neurology

VOLUME=Volume 13 - 2022

YEAR=2022

URL=https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2022.838222

DOI=10.3389/fneur.2022.838222

ISSN=1664-2295

ABSTRACT=COVID-19, the novel coronavirus disease, has been spreading worldwide. Vaccination can significantly reduce the mortality rate caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). There are several effective vaccines that have been introduced. Inactivated COVID-19 vaccine is one of these options and generally considered safe. We report a rare case of anti-NF186+ chronic inflammatory demyelinating polyneuropathy (CIDP) in a 23-year-old male patient who was vaccinated with inactivated COVID-19 vaccine. This report adds a possible rare side effect of a COVID-19 vaccine and provides a case for the clinical effectiveness of rituximab in patients with anti-NF186+ CIDP.